CLINICAL_TRIALS
trial_result
· 2009-02-04
Clinical Trial Update: Safety Study of Elvucitabine in HIV-1 Subjects [Phase 2]
Summary
The update reports on a Phase 2 safety study of elvucitabine in HIV-1–infected subjects that has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Thomas Jefferson University | Conditions: HIV Infections | Phase 2 | Status: COMPLETED